SCHEMBL10198566

SCHEMBL10198566

CC(C)(Oc1ccc(Oc2ccccc2)cc1)C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.57
PARP10 Q53GL7 1/20 0.55
PPARA Q07869 6/20 0.52
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
SRD5A2 P31213 1/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2822682 0.93 PPARA (0.54) PPARGPARP10PPARAKMT2AMEN1
SCHEMBL22209208 0.85 PPARG (0.74) PPARGPPARAKMT2AMEN1ALDH1A1
SCHEMBL19514689 0.81 PPARA (0.74) PPARGPPARARAB9AL3MBTL1MAPT
SCHEMBL19514688 0.81 PPARA (0.74) PPARGPPARARAB9AL3MBTL1MAPT
SCHEMBL3948925 0.79 PPARA (0.47) PPARGPARP10PPARAKMT2AMEN1
SCHEMBL4000649 0.79 PPARA (0.47) PPARGPARP10PPARAKMT2AMEN1
SCHEMBL11545612 0.79 PPARA (0.71) PPARGPPARAKMT2AMEN1ALDH1A1
SCHEMBL18260725 0.78 PPARA (0.46) PPARGPPARAKMT2AMEN1ALDH1A1
SCHEMBL3233909 0.78 KMT2A (0.47) PPARGPPARAKMT2AMEN1NPC1
SCHEMBL4688589 0.78 PPARA (0.48) PPARGPARP10PPARAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125735-B1 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2012-06-27 EP disclosed